LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 6.06 | 84.90 | 9 | 365 | 0.0246 | -0.6555 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 6.06 | 84.90 | 756 | 365 | 2.0687 | 1.8245 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 7.77 | 84.90 | 7 | 411 | 0.0170 | -0.6659 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 7.77 | 84.90 | 885 | 411 | 2.1520 | 1.8007 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 7.77 | 84.90 | 10 | 411 | 0.0243 | -0.6092 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 7.77 | 84.90 | 679 | 411 | 1.6511 | 1.4929 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 9.47 | 84.90 | 15 | 447 | 0.0335 | -0.5147 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 9.47 | 84.90 | 959 | 447 | 2.1434 | 1.7486 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 9.47 | 84.90 | 16 | 447 | 0.0358 | -0.5014 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 9.47 | 84.90 | 917 | 447 | 2.0495 | 1.6977 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 11.18 | 84.90 | 37 | 492 | 0.0751 | -0.2793 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 11.18 | 84.90 | 1079 | 492 | 2.1915 | 1.7252 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 11.18 | 84.90 | 32 | 492 | 0.0650 | -0.3194 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 11.18 | 84.90 | 743 | 492 | 1.5091 | 1.3523 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 12.88 | 84.90 | 38 | 531 | 0.0716 | -0.2621 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 12.88 | 84.90 | 1111 | 531 | 2.0923 | 1.6439 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 12.88 | 84.90 | 40 | 531 | 0.0753 | -0.2476 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 12.88 | 84.90 | 893 | 531 | 1.6817 | 1.4344 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 14.58 | 84.90 | 31 | 663 | 0.0467 | -0.2880 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 14.58 | 84.90 | 1115 | 663 | 1.6807 | 1.3826 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 14.58 | 84.90 | 46 | 663 | 0.0693 | -0.1867 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 14.58 | 84.90 | 602 | 663 | 0.9074 | 0.9356 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 16.29 | 84.90 | 35 | 766 | 0.0456 | -0.2435 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 16.29 | 84.90 | 1132 | 766 | 1.4762 | 1.2610 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 16.29 | 84.90 | 56 | 766 | 0.0730 | -0.1228 | MN20160318_Q02 | M18 |